Latest News and Press Releases

NEW YORK, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), and certain officers.   The...

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rivian Automotive, Inc. (“Rivian” or the “Company”) (NASDAQ: RIVN). Such investors are...

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA)....

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Allstate Corporation (“Allstate” or the “Company”) (NYSE: ALL). Such investors are...

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Olaplex Holdings, Inc. (“Olaplex” or the “Company”) (NASDAQ: OLPX).   Such investors are...

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Accelerate Diagnostics, Inc. (“Accelerate” or the “Company”) (NASDAQ: AXDX). Such...

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Seagate Technology Holdings plc (“Seagate” or the “Company”) (NASDAQ: STX). Such investors...

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pfizer Inc. (“Pfizer” or the “Company”) (NYSE: PFE).   Such investors are advised to...

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are advised...

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Freshworks Inc. (“Freshworks” or the “Company”) (NASDAQ: FRSH). Such investors are advised...